- EU Horizon Europe collaborative project (1/2023 – 12/2028): Inflammation in human early life: targeting impacts on life-course health (INITIALISE) – Coordinator (Oresic)
- Academy of Finland: Human exposure to per- and poly-fluoroalkyl substances – role of the gut microbiome and bile acid metabolism in mediating impact (PFASgut) – PI (Oresic)
- Collaborative project, Innovative Medicines Initiative: Translational approaches to disease modifying therapy of type 1 diabetes- HARVESTing the fruits of INNODIA (INNODIA HARVEST) – Participant (Oresic)
- COST action CA19105, Horizon 2020 Programme. LipidNET- Pan-European Network in Lipidomics and Epilipidomics. Working Group leader (Oresic), Clinical significance and applications of (epi)lipidomics
- Academy of Finland (Postdoctoral Research project): Metabolomics meet gut microbiome. A stepping stone towards type 1 diabetes prediction and prevention – PI (Lamichhane)
- Vetenskapsrådet: Blood-based metabolomics to predict severity and patient outcomes in traumatic brain injury – PI (Oresic)
- Collaborative project, EU Horizon 2020 Innovative Medicines Initiative: Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS) – Metabolomics Task Force leader (Oresic)
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkNoPrivacy policy